Clinical Trials

100 enrolled

Breast Neoplasms

NCT07391774 2026-04-13

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

1,978 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT07507188 2026-04-02

INSTAR

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07505186 2026-04-01

Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma

45 enrolled

Phase 1/2 Not yet recruiting

Esophageal Squamous Cell Carcinoma

NCT07498725 2026-03-27

A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors

120 enrolled

Tumor-Agnostic

Neoplasms

NCT07477808 2026-03-23

Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer

116 enrolled

Phase 1/2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07477444 2026-03-20

HER-OIC

29 enrolled

Gastroesophageal Cancer

NCT07472478 2026-03-16

GIVEN

32 enrolled

Phase 1/2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07472647 2026-03-16

SYS6090 Combination Therapy in Advanced Lung Cancer

596 enrolled

Phase 2/3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07454720 2026-03-06

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II/III Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

165 enrolled

Locally Advanced Resectable Rectal Cancer

NCT07440901 2026-02-27

Remodeling of MHC-related Immune Microenvironment in MIBC After Neoadjuvant Therapy

Not yet recruiting

30 enrolled

Genitourinary

Muscle-invasive Bladder Cancer

NCT07432087 2026-02-25

Camrelizumab Combined With EGFR Monoclonal Antibody or Chemotherapy for Perioperative Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

246 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07425054 2026-02-20

HPV ctDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Advanced-Stage Anal Cancer

33 enrolled

Anus Neoplasms

NCT07397442 2026-02-11

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

19 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT07381309 2026-02-02

VVSHIP

114 enrolled

CRC

NCT06952621 2026-01-30

TD-NEOE3V3

390 enrolled

Esophageal Squamous Cell Carcinoma

NCT07378306 2026-01-30

FACT-TN

80 enrolled

Phase 1 Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07335380 2026-01-29

Lattice-Based Radiotherapy and Chemo-Immunotherapy for Oral Cavity Squamous Cell Carcinoma

30 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07372079 2026-01-28

Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemotherapy

40 enrolled

Breast Neoplasms

NCT07358676 2026-01-22

A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer

25 enrolled